www.fgks.org   »   [go: up one dir, main page]

Top Medical News from Across Medscape

  • FDA Plans to Curb Nicotine Levels in TobaccoThe FDA has announced it will pursue lowering the nicotine content in cigarettes to nonaddictive levels as part of an overall plan to protect youth and reduce tobacco-related disease and death.
  • First-Episode Psychosis Drug Choice: No Clear WinnerAfter first-episode psychosis, haloperidol should not be used, and the choice among second-generation antipsychotics should be guided by their side effect profile, new research suggests.
  • Rituximab Biosimilars Shown to Be Safe and EffectiveTwo randomized trials confirm that two new biosimilars that have recently been introduced in Europe are efficacious and comparable to the reference product. Other biosimilars are on the way.
  • DEWS II: New Dry Eye Report Updates ResearchThe International Dry Eye Workshop II report from the Tear Film and Ocular Surface Society discusses every facet of the disease and the additional research that is still needed.
  • Smoking-Cessation Drug Prescriptions Rarely Filled Post-MIA new study shows physicians almost always advise patients to stop smoking during hospitalization for an MI, but the advice doesn't appear to translate into prescriptions filled for smoking-cessation drugs.

Special Report

  • Healthcare policy is the number one topic -- not just in Washington, DC but in hospitals, medical practices, and homes. With so much happening on so many fronts, it's hard to keep up. Let us do it for you.

Business of Medicine

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California